ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Anti-Ageing
Preclinical

MOTS-c

MOTS-c

Also known as: MOTS-c peptide, Mitochondrial-Derived Peptide

Overview

Key Facts

Primary Goal: A mitochondrial-derived peptide encoded in the 12S rRNA gene that acts as a metabolic regulator

A mitochondrial-derived peptide encoded in the 12S rRNA gene that acts as a metabolic regulator. MOTS-c activates AMPK signaling, enhances glucose metabolism, and improves exercise capacity, positioning it as a novel approach to metabolic health and weight management. Half-Life ~4-6 hours (estimated) Typical Dose 5–10 mg Frequency 3-5 times per week Cycle Length 4-8 weeks on, 4 weeks off

Dosing Information

Half-Life

~4-6 hours (estimated)

Typical Dose

5–10 mg

Frequency

3-5 times per week

Cycle Length

4-8 weeks on, 4 weeks off

Administration Routes:

subcutaneousintravenous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

Discovered by Dr. Pinchas Cohen's lab at USC, MOTS-c has shown in animal studies to improve metabolic homeostasis, enhance exercise capacity, and protect against age-related metabolic decline. It activates AMPK in skeletal muscle, promoting glucose metabolism. Human observational studies correlate higher endogenous MOTS-c levels with better metabolic health. Clinical trials in humans are still in early stages.

Frequently Asked Questions

Common questions about MOTS-c

UK-Specific Information

Exclusive data points and guidance for UK residents using MOTS-c

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With